National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

sabarubicin
A disaccharide analogue of the anthracycline antineoplastic antibiotic doxorubicin. Sabarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent also induces apoptosis through a p53-independent mechanism. Sabarubicin is less cardiotoxic than doxorubicin. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code names:BMS-195615
MEN-10755



Previous:ruthenium Ru 106, S-1, S-3304, S-adenosyl-L-methionine disulfate p-toluene-sulfonate, S-CKD602
Next:safingol, Salagen, salinosporamide A, salirasib, salmonella VNP20009

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov